123 related articles for article (PubMed ID: 3876218)
1. Quantitative and functional abnormalities of total T lymphocytes in relatives of patients with Hodgkin's disease.
del Giacco GS; Cengiarotti L; Mantovani G; Murgia M; Broccia G; Corda G; di Tucci A
Eur J Cancer Clin Oncol; 1985 Jul; 21(7):793-801. PubMed ID: 3876218
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
3. Peripheral blood lymphocyte response to recombinant and non-recombinant interleukin 2 in previously treated patients with Hodgkin's disease, long-time off-therapy.
Mantovani G; Coiana A; Massidda A; Locci F; Loy M; Piludu G; Piras MC; Macciò A; Del Giacco GS
Eur J Haematol; 1987 Feb; 38(2):179-86. PubMed ID: 3496236
[TBL] [Abstract][Full Text] [Related]
4. Hodgkin's disease in children: investigation of T and B lymphocytes.
Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
[TBL] [Abstract][Full Text] [Related]
5. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
[TBL] [Abstract][Full Text] [Related]
6. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
Lang JM; Bigel P; Oberling F; Mayer S
Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
[TBL] [Abstract][Full Text] [Related]
7. PHA dose dependent defect in lymphocyte stimulation and E-rosette-forming cells in untreated Hodgkin's disease.
Land JM; Litwin J; Bigel P; Oberling F; Mayer S
Acta Haematol Pol; 1977; 8(2):131-4. PubMed ID: 329629
[TBL] [Abstract][Full Text] [Related]
8. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
[TBL] [Abstract][Full Text] [Related]
9. T-lymphocyte subpopulations in B-cell-derived non-Hodgkin's lymphomas and Hodgkin's disease.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1984 Aug; 54(4):644-51. PubMed ID: 6234982
[TBL] [Abstract][Full Text] [Related]
10. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
11. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
[TBL] [Abstract][Full Text] [Related]
12. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
Han T
Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
[TBL] [Abstract][Full Text] [Related]
13. Immunological family studies in Hodgkin's disease. Is the immunodeficiency horizontally transmitted?
Björkholm M; Holm G; Mellstedt H
Scand J Haematol; 1978 Apr; 20(4):297-305. PubMed ID: 653309
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between skin reactivity and T lymphocytes and monocytes in Hodgkin's disease.
Müftüoğlu AU; Yalçin B
Acta Haematol; 1980; 63(5):286-8. PubMed ID: 6774558
[TBL] [Abstract][Full Text] [Related]
15. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
16. Immunologic profile in patients with Hodgkin's disease in complete remission.
Liberati AM; Ballatori E; Fizzotti M; Schippa M; Proietti MG; Di Marzio R; Pecci A; Biscetti L; Sbarretti R; Cini L
Cancer; 1987 Jun; 59(11):1906-13. PubMed ID: 3105863
[TBL] [Abstract][Full Text] [Related]
17. In vitro lymphocyte dysfunction in Hodgkin's disease.
Graze PR; Perlin E; Royston I
J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
[TBL] [Abstract][Full Text] [Related]
18. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
Han T; Minowada J; Subramanian V; Barcos M; Kim U
Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
[TBL] [Abstract][Full Text] [Related]
19. Induction of suppressor cells to T- and B-cell proliferative responses and immunoglobulin production by monoclonal antibodies recognizing the CD3 T-cell differentiation antigen.
Kunicka JE; Platsoucas CD
Cell Immunol; 1988 Oct; 116(1):195-215. PubMed ID: 2901914
[TBL] [Abstract][Full Text] [Related]
20. Quantitation of T and B lymphocytes and cellular immune function in Hodgkin's disease.
Bobrove AM; Fuks Z; Strober S; Kaplan HS
Cancer; 1975 Jul; 36(1):169-79. PubMed ID: 54208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
